References
- Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988;41:155–78
- Benzi G. Pharmacological features of an almitrine-raubasine combination. Eur Neurol 1998;39(Suppl):31–8
- Charpenter J. The fundamental stage: the pharmacological action of Duxil. Praticien 1980;372:15–21
- Chan P, Li Y, Zheng Z. Neurologic and histologic evaluation of almitrine + raubasine (Duxil) in middle cerebral artery occlusion in cats. Eur J Pharmacol 1993;231:175–82
- Guez D. Evaluation of acute and chronic cerebral ischaemia in human by positron and single photon emission tomography. Application to the study of Duxil. Rev Med Intern 1988;91(Suppl):33–9
- Allain H, Benture-Ferrrer D. Clinical efficacy of almitrine–raubasine. Eur Neurol 1998;39:39–44
- Grel P, Menard AM. Therapeutic activity of Duxil in intellectual and behavioural disorders associated with chronic cerebral insufficiency. Double blind controlled trial against placebo. Psychol Med. 1984;16:181–9
- Pardo A. Therapeutic activity of Duxil in intellectual and behavioural disorders in chronic cerebral impairment. Double blind placebo controlled trial using psychometric tests. J Int Med 1986;73:14–20
- Saletu B, Grunberger J, Linzmayer L, Anderer P. Double blind placebo controlled quantitative EEG and psychometric studies in the elderly on vigilance. Promoting effects of almitrine–raubasine combination. Arch Gerontol Geriatr 1988;7:93–110
- Bailly A, Roux C. Etude comparative contre placebo de l’action de Duxil dans l’insuffisance circulatoire cerebrale du sujet age. CR Ther Pharmacol Clin 1982;1:19–27
- Le Poncin M, Chouckroun E. Clinical and psychometric evaluation of the effects of Duxil on cognitive disorders of the elderly. J Neurol 1988;235(Suppl):S56
- Rapisarda V, Azzaro E, Fichera G. Evaluation psychometrique des effets de l’association almitrine-raubasine sur l’affaiblissement intellectuel du sujet age. Essai controle a double insu contre placebo. Presse Med 1987;16:1163–6
- Tsai N, Gao ZX. Validity of Hasegawa’s Dementia Scale for screening dementia among aged Chinese. Int Psychogeriatr 1989;1(2):145–52
- Poitrenaud J, Laurent B, Sebban C. Memory disorders in 8037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine–raubasine. Eur Neurol 1995;35(Suppl):43–6